186 related articles for article (PubMed ID: 29441675)
1. Uterine adenosarcoma in Japan: Clinicopathologic features, diagnosis and management.
Tate K; Watanabe R; Yoshida H; Shimizu H; Uehara T; Ishikawa M; Ikeda SI; Hiraoka N; Kato T
Asia Pac J Clin Oncol; 2018 Aug; 14(4):318-325. PubMed ID: 29441675
[TBL] [Abstract][Full Text] [Related]
2. Uterine Adenosarcoma.
Ulrich UA; Denschlag D
Oncol Res Treat; 2018; 41(11):693-696. PubMed ID: 30326467
[TBL] [Abstract][Full Text] [Related]
3. Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence.
Carroll A; Ramirez PT; Westin SN; Soliman PT; Munsell MF; Nick AM; Schmeler KM; Klopp AH; Fleming ND
Gynecol Oncol; 2014 Dec; 135(3):455-61. PubMed ID: 25449308
[TBL] [Abstract][Full Text] [Related]
4. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
5. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes.
Nathenson MJ; Conley AP; Lin H; Fleming N; Lazar A; Wang WL; Ravi V
Int J Gynecol Cancer; 2018 Sep; 28(7):1297-1310. PubMed ID: 30044322
[TBL] [Abstract][Full Text] [Related]
6. Uterine adenosarcomas: a dual-institution update on staging, prognosis and survival.
Bernard B; Clarke BA; Malowany JI; McAlpine J; Lee CH; Atenafu EG; Ferguson S; Mackay H
Gynecol Oncol; 2013 Dec; 131(3):634-9. PubMed ID: 24135678
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for uterine adenosarcoma: a review.
Nathenson MJ; Conley AP
Expert Rev Anticancer Ther; 2018 Nov; 18(11):1093-1100. PubMed ID: 30169984
[TBL] [Abstract][Full Text] [Related]
8. Uterine Adenosarcoma: a Review.
Nathenson MJ; Ravi V; Fleming N; Wang WL; Conley A
Curr Oncol Rep; 2016 Nov; 18(11):68. PubMed ID: 27718181
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases.
Omi M; Tonooka A; Chiba T; Tanaka Y; Fusegi A; Aoki Y; Nomura H; Kanao H; Takazawa Y
Diagn Pathol; 2020 Sep; 15(1):119. PubMed ID: 32972432
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of uterine preservation in the management of early-stage uterine adenosarcomas: a single institute experience.
Lee YJ; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
World J Surg Oncol; 2017 Apr; 15(1):87. PubMed ID: 28424089
[TBL] [Abstract][Full Text] [Related]
11. High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior.
Hodgson A; Amemiya Y; Seth A; Djordjevic B; Parra-Herran C
Am J Surg Pathol; 2017 Nov; 41(11):1513-1522. PubMed ID: 28834809
[TBL] [Abstract][Full Text] [Related]
12. Management of uterine adenosarcomas with and without sarcomatous overgrowth.
Tanner EJ; Toussaint T; Leitao MM; Hensley ML; Soslow RA; Gardner GJ; Jewell EL
Gynecol Oncol; 2013 Apr; 129(1):140-4. PubMed ID: 23283300
[TBL] [Abstract][Full Text] [Related]
13. Müllerian adenosarcoma: a review of cases and literature.
Huang PS; Chang WC; Huang SC
Eur J Gynaecol Oncol; 2014; 35(6):617-20. PubMed ID: 25556263
[TBL] [Abstract][Full Text] [Related]
14. Mullerian adenosarcoma (heterologous) of uterine cervix with sarcomatous overgrowth: A case report with review of the literature.
Mohapatra D; Mohanty P; Biswal R
Indian J Pathol Microbiol; 2019; 62(1):139-141. PubMed ID: 30706880
[TBL] [Abstract][Full Text] [Related]
15. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study.
Seagle BL; Kanis M; Strohl AE; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):636-641. PubMed ID: 27771166
[TBL] [Abstract][Full Text] [Related]
16. Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review.
Mandato VD; Torricelli F; Mastrofilippo V; Valli R; Aguzzoli L; La Sala GB
BMC Cancer; 2018 Feb; 18(1):134. PubMed ID: 29402239
[TBL] [Abstract][Full Text] [Related]
17. [Adenosarcoma and other uterine sarcomas].
Schindler S; Gratia P; Müllenberger G; Arendt J
Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(2):27-30. PubMed ID: 9534271
[TBL] [Abstract][Full Text] [Related]
18. Uterine Adenosarcoma with Sarcomatous Overgrowth: A Case Report of Aggressive Disease in a 16-Year-Old Girl and a Literature Review.
Liu H; Shen Z; Wu D; Zhou Y
J Pediatr Adolesc Gynecol; 2018 Aug; 31(4):426-431. PubMed ID: 29317258
[TBL] [Abstract][Full Text] [Related]
19. Uterine and Cervical Adenosarcoma: A Retrospective Study of Overall Oncologic Outcomes and Fertility Preservation in Early-Stage Disease.
Yuan Z; Cao D; Yu M; Shen K; He Y
Oncologist; 2019 Sep; 24(9):e870-e879. PubMed ID: 31127022
[TBL] [Abstract][Full Text] [Related]
20. Clinical management of uterine cervical mullerian adenosarcoma: A clinicopathological study of six cases and review of the literature.
Togami S; Kawamura T; Fukuda M; Yanazume S; Kamio M; Kobayashi H
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):479-482. PubMed ID: 30122564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]